연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
3565. Protection against tuberculosis by vaccination of secreted chorismate mutase (Rv1885c) combined with a hepatitis B virus (HBV)-derived peptide, Poly6, and alum adjuvants
Hyejun Seo, Byung-Jun Kim, Jaehun Oh, Sangkwon Jung, Ju-Young Lee, Bum-Joon Kim
Vaccine. 2025 Feb; 47, 126710
Link
3564. PreS1 deletions in genotype C HBV leads to severe hepatic inflammation and hepatocarcinogenesis via the IRE1-JNK axis
Yu-Min Choi, Junghwa Jang, Dong Hyun Kim, Ziyun Kim, Eunseo Kim, Won Hyeok Choe, Bum-Joon Kim
JHEP Reports. 2025 Mar; 7(3), 101274
Link
3563. The sV184A Variant in HBsAg Specific to HBV Subgenotype C2 Leads to Enhanced Viral Replication and Apoptotic Cell Death Induced by PERK‐eIF2α‐CHOP‐Mediated ER Stress
Yu‐Min Choi, Dong Hyun Kim, Eun Ju Cho, Ziyun Kim, Junghwa Jang, Hyunsoo Kim, Su Jong Yu, Bum‐Joon Kim
Journal of Medical Virology. 2025 Feb; 97(2), e70253
Link
3562. Predictive role of tumor-infiltrating lymphocytes and immune phenotype for pembrolizumab in relapsed or refractory thymic carcinoma
Kim DH, Lim Y, Song S, Ock CY, Youk J, Kim M, Kim TM, Kim DW, Kim HJ, Koh J, Jung KC, Na KJ, Kang CH, Keam B.
J Thorac Dis. 2025 Jul 31;17(7):4409-4419. doi: 10.21037/jtd-2025-526. Epub 2025 Jul 28.
Link
3561. Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer with leptomeningeal metastases: the KCSG LU 21-01, LAZARUS study
Jung HA, Kim TM, Kim HR, Kim CG, Ahn HK, Lee Y, Kim YJ, Kim M, Youk J, Sun JM, Lee SH, Ahn JS, Kim DW, Ahn MJ, Keam B.
Lung Cancer. 2025 Nov 1;210:108809. doi: 10.1016/j.lungcan.2025.108809. Online ahead of print.
Link
3560. Cell free supernatants of Bifidobacterium adolescentis and Bifidobacterium longum suppress the tumor growth in colorectal cancer organoid model
Min Jung Kim, Myoung-Hyun Song, Yo-Sep Ji, Ji Won Park, Young-Kyoung Shin, Soon-Chan Park, Gihyeon Kim, Beomki Cho, Hansoo Park, Ja-Lok Ku, Seung-Yong Jeong
Scientific Reports 2025;15:935
Link
3559. The Synergistic Effect of PARP Inhibitors and Irinotecan in Small Cell Lung Cancer Cells
Oh S, Kim S, Keam B, Youk J, Kim TM, Kim DW, Kim M.
Cancer Res Treat. 2025 Jan 7. doi: 10.4143/crt.2024.728. Online ahead of print.
Link
3558. Genomic profiling of intimal sarcoma reveals molecular subtypes with distinct tumor microenvironments and therapeutic implications
Park C, Kim R, Bae JM, Lee T, Song S, Kwak Y, Lee KB, Youk J, Keam B, Kim TM, Kim DW, Kim JI, Choi J, Kim M.
ESMO Open. 2025 Jan;10(1):104097. doi: 10.1016/j.esmoop.2024.104097. Epub 2025 Jan 7.
Link
3557. A Phase II Study of Durvalumab, Doxorubicin, and Ifosfamide in Recurrent and/or Metastatic Pulmonary Sarcomatoid Carcinoma (KCSG LU-19-24)
Kim M, Youk J, Kim TM, Lee GW, Kim DW, Keam B.
Clin Lung Cancer. 2025 Oct 11:S1525-7304(25)00243-8. doi: 10.1016/j.cllc.2025.10.003. Online ahead of print.
Link
3556. NFAT5 dictates crosstalk between intestinal epithelial regenerative capacity and microbiota in murine colitis models
Se-Hyeon Park 1 2, Dae Hee Cheon 3 4, Yu-Mi Kim 1 2, Yeji Choi 3 4, Yong-Joon Cho 5 6, Bong-Ki Hong 1 2, Sang-Hyun Cho 7, Mi-Na Kweon 8, Hyug Moo Kwon 9, Eugene B Chang 10, Donghyun Kim 3 4 11 12, Wan-Uk Kim 1 2 13
J Clin Invest. 2025 Jul 15;135(18):e183093.
Link